Infliximab
Indication
Juvenile Idiopathic Arthritis (JIA) in Adult Patients
Red
Brand:
Remicade®, Inflectra®, Remsima®
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Musculoskeletal system
Background
Treatment with infliximab for adults with JIA is recommended ONLY in the following circumstances in Lancashire and South Cumbria:
Young people with JIA currently being treated with one of the agents and transferring over from adolescent to adult services and are benefiting from a clinically effective response
Recommendation
LSCMMG Recommendation:
Red
Reason for decision:
Specialist medicine
Supporting documents: